Full Text View
Tabular View
No Study Results Posted
Related Studies
Intramuscular Peramivir for the Treatment of Uncomplicated Influenza
This study has been withdrawn prior to enrollment.
( This study was withdrawn for administrative reasons. The dose ranging plan for the program was revised". )
Study NCT00486980   Information provided by BioCryst Pharmaceuticals

First Received on June 14, 2007.   Last Updated on January 28, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Influenza
Additional conditions recognized in this trial
Influenza, Human
More general conditions related to this trial
Orthomyxoviridae Infections
Respiratory Tract Diseases
Respiratory Tract Infections
RNA Virus Infections
Virus Diseases
Interventions listed in this trial
Peramivir 150mg
Peramivir 300mg
Sponsors listed in this trial
BioCryst Pharmaceuticals


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services